» Articles » PMID: 29947927

Mechanisms of Protein Toxicity in Neurodegenerative Diseases

Overview
Publisher Springer
Specialty Biology
Date 2018 Jun 28
PMID 29947927
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Protein toxicity can be defined as all the pathological changes that ensue from accumulation, mis-localization, and/or multimerization of disease-specific proteins. Most neurodegenerative diseases manifest protein toxicity as one of their key pathogenic mechanisms, the details of which remain unclear. By systematically deconstructing the nature of toxic proteins, we aim to elucidate and illuminate some of the key mechanisms of protein toxicity from which therapeutic insights may be drawn. In this review, we focus specifically on protein toxicity from the point of view of various cellular compartments such as the nucleus and the mitochondria. We also discuss the cell-to-cell propagation of toxic disease proteins that complicates the mechanistic understanding of the disease progression as well as the spatiotemporal point at which to therapeutically intervene. Finally, we discuss selective neuronal vulnerability, which still remains largely enigmatic.

Citing Articles

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Incidence of optic nerve kinking in a cohort of patients with Normal tension glaucoma.

Pircher A, Berberat J, Remonda L, Roberts C, Neutzner A, Killer H Eye (Lond). 2025; .

PMID: 39827239 DOI: 10.1038/s41433-025-03608-5.


A Drosophila model for mechanistic investigation of tau protein spread.

Bankapalli K, Thomas R, Vincow E, Milstein G, Fisher L, Pallanck L Dis Model Mech. 2024; 17(9).

PMID: 39350752 PMC: 11463956. DOI: 10.1242/dmm.050858.


Novel strategies in Parkinson's disease treatment: a review.

Mitchell C, Kurouski D Front Mol Neurosci. 2024; 17:1431079.

PMID: 39183754 PMC: 11341544. DOI: 10.3389/fnmol.2024.1431079.


Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity.

Kitamura A, Fujimoto A, Kawashima R, Lyu Y, Sasaki K, Hamada Y Commun Biol. 2024; 7(1):743.

PMID: 38902525 PMC: 11190292. DOI: 10.1038/s42003-024-06410-3.


References
1.
Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

2.
Hockly E, Richon V, Woodman B, Smith D, Zhou X, Rosa E . Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A. 2003; 100(4):2041-6. PMC: 149955. DOI: 10.1073/pnas.0437870100. View

3.
Kwon M, Kim J, Kim T, Lee S . Pharmacological intervention of early neuropathy in neurodegenerative diseases. Pharmacol Res. 2017; 119:169-177. DOI: 10.1016/j.phrs.2017.02.003. View

4.
Takahara T, Maeda T . Transient sequestration of TORC1 into stress granules during heat stress. Mol Cell. 2012; 47(2):242-52. DOI: 10.1016/j.molcel.2012.05.019. View

5.
Freibaum B, Lu Y, Lopez-Gonzalez R, Kim N, Almeida S, Lee K . GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015; 525(7567):129-33. PMC: 4631399. DOI: 10.1038/nature14974. View